C. difficile Toxin and Glutamate Dehydrogenase (GDH)
C. difficile toxins (A and/or B) are the disease-causing proteins produced by toxigenic strains of Clostridioides difficile, while glutamate dehydrogenase (GDH) is a metabolic enzyme produced in large amounts by all C. difficile strains—both toxigenic and non-toxigenic—making it a sensitive but non-specific marker for the organism's presence.
Understanding C. difficile Toxins
C. difficile infection (CDI) is caused exclusively by toxigenic strains that produce toxin A and/or toxin B 1. These toxins are the actual pathogenic factors responsible for:
- Intestinal inflammation
- Diarrhea
- Pseudomembranous colitis
- Tissue damage in the colon
Only the presence of toxins or toxin-producing strains causes disease—this is a critical distinction because approximately 7% of hospitalized patients may be colonized with toxigenic C. difficile without having active infection 1.
Understanding Glutamate Dehydrogenase (GDH)
GDH is an NAD-specific enzyme that converts L-glutamate into α-ketoglutarate 2. Key characteristics include:
- Produced by ALL C. difficile strains (both toxigenic and non-toxigenic) 1
- Produced in relatively large amounts compared to toxins A and B 1
- Highly conserved across the C. difficile species 3, 4
- Secreted into stool and detectable in fecal samples 2, 4
Critical Limitation of GDH Testing
A positive GDH test only documents the presence of C. difficile but does NOT discriminate between toxigenic (disease-causing) and non-toxigenic strains 1. Since approximately 20% of the C. difficile population consists of non-toxigenic strains 1, a second confirmatory test for toxin production is necessary when GDH is positive 1.
Diagnostic Performance
GDH Testing
- Sensitivity: 90-100% 1, 4, 5
- Specificity: 80-95% 4, 5
- Negative Predictive Value: 99-100% 4, 6, 5
- Positive Predictive Value: 57-82% (requires confirmation) 4, 5
Toxin A/B Testing
Clinical Application in Diagnostic Algorithms
The 2019 WSES guidelines recommend using GDH as a screening test in combination with toxin A/B enzyme immunoassays, with algorithms starting with GDH followed by a toxin assay 1. This two-step approach provides:
- High sensitivity from the GDH screen (catches nearly all cases)
- High specificity from the toxin confirmation (rules out non-toxigenic colonization)
- Rapid turnaround time (both tests complete within hours)
- Cost-effectiveness compared to molecular testing alone 1
Practical Interpretation
- GDH negative = Effectively rules out CDI (NPV ~100%) 4, 6
- GDH positive/Toxin positive = Confirms CDI
- GDH positive/Toxin negative = Requires additional testing (NAAT) or clinical correlation, as 63% may still harbor toxigenic strains 7, 8
Common pitfall: Do not use GDH testing alone for diagnosis, as it cannot distinguish between colonization and infection 1. Always pair with toxin detection or molecular methods for positive GDH results.